TWI885097B - 含戊酸倍他米松(betamethasone valerate)之組成物 - Google Patents

含戊酸倍他米松(betamethasone valerate)之組成物 Download PDF

Info

Publication number
TWI885097B
TWI885097B TW110110082A TW110110082A TWI885097B TW I885097 B TWI885097 B TW I885097B TW 110110082 A TW110110082 A TW 110110082A TW 110110082 A TW110110082 A TW 110110082A TW I885097 B TWI885097 B TW I885097B
Authority
TW
Taiwan
Prior art keywords
composition
polyoxyethylene
component
stability
aforementioned
Prior art date
Application number
TW110110082A
Other languages
English (en)
Chinese (zh)
Other versions
TW202200155A (zh
Inventor
村里博志
友田宜孝
岩田洋一
純浦文枝
Original Assignee
日商塩野義醫藥保健股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商塩野義醫藥保健股份有限公司 filed Critical 日商塩野義醫藥保健股份有限公司
Publication of TW202200155A publication Critical patent/TW202200155A/zh
Application granted granted Critical
Publication of TWI885097B publication Critical patent/TWI885097B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW110110082A 2020-03-19 2021-03-19 含戊酸倍他米松(betamethasone valerate)之組成物 TWI885097B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-049760 2020-03-19
JP2020049760 2020-03-19

Publications (2)

Publication Number Publication Date
TW202200155A TW202200155A (zh) 2022-01-01
TWI885097B true TWI885097B (zh) 2025-06-01

Family

ID=77770984

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110110082A TWI885097B (zh) 2020-03-19 2021-03-19 含戊酸倍他米松(betamethasone valerate)之組成物

Country Status (3)

Country Link
JP (1) JP7350985B2 (https=)
TW (1) TWI885097B (https=)
WO (1) WO2021187593A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008152444A2 (en) * 2006-11-29 2008-12-18 Foamix Ltd. Foamable waterless compositions with modulating agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09110696A (ja) * 1995-10-18 1997-04-28 Sekisui Chem Co Ltd 皮膚疾患治療用外用剤
PL199123B1 (pl) * 1999-04-23 2008-08-29 Leo Pharm Prod Ltd Niewodna kompozycja farmaceutyczna do stosowania naskórnego i jej zastosowanie
JP4690672B2 (ja) 2004-07-20 2011-06-01 岩城製薬株式会社 乳剤性皮膚外用剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008152444A2 (en) * 2006-11-29 2008-12-18 Foamix Ltd. Foamable waterless compositions with modulating agents

Also Published As

Publication number Publication date
JP7350985B2 (ja) 2023-09-26
WO2021187593A1 (ja) 2021-09-23
JPWO2021187593A1 (https=) 2021-09-23
TW202200155A (zh) 2022-01-01

Similar Documents

Publication Publication Date Title
WO2020214855A1 (en) Topical compositions and methods for treating inflammatory skin diseases
JP2011504870A (ja) ビタミンｄ誘導体および任意にステロイド系抗炎症剤を含む、ワセリンフリーの軟膏形態にある新規組成物
CN101808639A (zh) 抗真菌医药组合物
WO1999059580A1 (en) Preventives/remedies for skin diseases
EP3927319A1 (en) Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disorders
WO2022022434A1 (zh) 含托法替尼药学上可接受的盐的药物组合物、制剂及应用
EP4196477A1 (en) Tofacitinib-containing anhydrous elastomer-based gel formulations
JP2006028123A (ja) 乳剤性皮膚外用剤
CN113730335B (zh) 一种托法替布外用药物组合物及其应用
JP2023139134A (ja) 皮膚疾患を治療するためのフェノルドパム局所製剤
TWI885097B (zh) 含戊酸倍他米松(betamethasone valerate)之組成物
JP7346712B2 (ja) ベタメタゾン吉草酸エステル含有医薬組成物
JP2023044680A (ja) ベタメタゾン吉草酸エステル及びジフェンヒドラミン含有医薬組成物
TWI903311B (zh) 局部藥物組合物、其製備方法及其在醫藥上的用途
JPWO2004112837A1 (ja) 非ステロイド系消炎鎮痛剤含有外用経皮製剤およびインターロイキン−１α生成抑制剤
KR20020068385A (ko) 소양증 치료용 외용제
JP2023044681A (ja) ベタメタゾン吉草酸エステル含有軟膏剤
JP5961062B2 (ja) 皮膚外用剤組成物
JP7361448B2 (ja) トランスグルタミナーゼ発現促進剤
JP6503627B2 (ja) 医薬液体組成物
JP2016023170A (ja) 外用組成物
US20110144213A1 (en) Anhydrous depigmenting compositions comprising a solubilized phenolic compound
JP4060347B2 (ja) ２２−オキサ−１α，２５−ジヒドロキシビタミンＤ３を含有する水中油型乳剤性ローション剤
JP7309215B2 (ja) 皮膚外用剤
JP3193028B2 (ja) ニトロイミダゾール系化合物を含むアトピー性皮膚炎治療用の外用剤